The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Open accessAbstract
Background/Aims: There is little published data on the role of FOXP3 in gastric cancer. Methods: FOXP3 expression and localization in gastric cancer tissues and cells were examined by immunohistochemistry, RT-PCR, flow cytometry, western blot, and laser confocal microscopy. CCK8, plate clone, wound healing, and transwell insert assays were performed for gastric cancer cells. Potential molecules and signaling pathways were screened using high-throughput transcriptome sequencing. Results: FOXP3 expression in gastric cancer tissues was higher than that in para-carcinoma tissues. It was restricted to the cytoplasm of para-carcinoma tissues, but was observed in the cytoplasm or/and nuclei of gastric cancer tissues. FOXP3 expression was positively correlated with pathological grading, and was detected in gastric cancer and GES-1 cells, where it was expressed in the cytoplasm alone, or in both the cytoplasm and the nucleus. FOXP3 overexpression promoted cell proliferation, migration, and invasion, while FOXP3 knockdown suppressed these effects. Furthermore, RT-PCR and ELISA confirmed that FOXP3 upregulation resulted in increased TGF-β expression and secretion in gastric cancer cells. Conclusion: FOXP3 expression was associated with degree of gastric cancer differentiation. In addition, upregulated and ectopic tumoral FOXP3 can promote gastric cancer proliferation, migration, and invasion, partly through the TGF-β pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citationZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Gao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110
Szász, A. M., Lánczky, A., Nagy, Á., Förster, S., Hark, K., Green, J. E., Boussioutas, A., Busuttil, R., Szabó, A., & Győrffy, B. (2016) · Oncotarget · doi:10.18632/oncotarget.10337 · Cited by 988
Ziegler, S. F. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090547 · Cited by 922
Hiraoka, N., Onozato, K., Kosuge, T., & Hirohashi, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0369 · Cited by 831
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., & Ziegler, S. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104521200 · Cited by 548
Self-citationTwo Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
Ito, T., Hanabuchi, S., Wang, Y.-H., Park, W. R., Arima, K., Bover, L., Qin, F. X.-F., Gilliet, M., & Liu, Y.-J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.018 · Cited by 539
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Jarnicki, A. G., Lysaght, J., Todryk, S., & Mills, K. H. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.896 · Cited by 445
Petersen, R. P., Campa, M. J., Sperlazza, J., Conlon, D., Joshi, M., Harpole, D. H., & Patz, E. F. (2006) · Cancer · doi:10.1002/cncr.22282 · Cited by 433
FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis
Kobayashi, N., Hiraoka, N., Yamagami, W., Ojima, H., Kanai, Y., Kosuge, T., Nakajima, A., & Hirohashi, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2363 · Cited by 431
Forkhead-box transcription factors and their role in the immune system
Coffer, P. J., & Burgering, B. M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1488 · Cited by 401
Zuo, T., Wang, L., Morrison, C., Chang, X., Zhang, H., Li, W., Liu, Y., Wang, Y., Liu, X., Chan, M. W. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.034 · Cited by 395
Self-citationZheng, S. G., Wang, J., & Horwitz, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7112 · Cited by 356
Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer
Hinz, S., Pagerols-Raluy, L., Oberg, H.-H., Ammerpohl, O., Grüssel, S., Sipos, B., Grützmann, R., Pilarsky, C., Ungefroren, H., Saeger, H.-D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3304 · Cited by 352
Yes-associated protein (YAP) functions as a tumor suppressor in breast
Yuan, M., Tomlinson, V, Lara, R., Holliday, D., Chelala, C., Harada, T., Gangeswaran, R., Manson-Bishop, C., Smith, P., Danovi, S. A., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.108 · Cited by 335
FOXP3 Expression and Overall Survival in Breast Cancer
Merlo, A., Casalini, P., Carcangiu, M. L., Malventano, C., Triulzi, T., Mènard, S., Tagliabue, E., & Balsari, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9036 · Cited by 301
Foxp3: a critical regulator of the development and function of regulatory T cells
Hori, S., & Sakaguchi, S. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.020 · Cited by 291
Kang, W., Tong, J. H. M., Chan, A. W. H., Lee, T.-L., Lung, R. W. M., Leung, P. P. S., So, K. K. Y., Wu, K., Fan, D., Yu, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2467 · Cited by 259
Tao, H., Mimura, Y., Aoe, K., Kobayashi, S., Yamamoto, H., Matsuda, E., Okabe, K., Matsumoto, T., Sugi, K., & Ueoka, H. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.06.002 · Cited by 253
FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2
Zuo, T., Liu, R., Zhang, H., Chang, X., Liu, Y., Wang, L., Zheng, P., & Liu, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32538 · Cited by 249
Self-citationShimizu, K., Nakata, M., Hirami, Y., Yukawa, T., Maeda, A., & Tanemoto, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d60fd7 · Cited by 244
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Wang, L., Liu, R., Li, W., Chen, C., Katoh, H., Chen, G.-Y., McNally, B., Lin, L., Zhou, P., Zuo, T., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.016 · Cited by 218
Self-citationSamon, J. B., Champhekar, A., Minter, L. M., Telfer, J. C., Miele, L., Fauq, A., Das, P., Golde, T. E., & Osborne, B. A. (2008) · Blood · doi:10.1182/blood-2008-03-144980 · Cited by 191
The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Ebert, L. M., Tan, B. S., Browning, J., Svobodova, S., Russell, S. E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S. P., MacGregor, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5664 · Cited by 183
Expression of survivin and Bcl-2 in the normal human endometrium
Konno, R. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.6.529 · Cited by 152
Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity
Nair, S. K., Boczkowski, D., Faßnacht, M., Pisetsky, D. S., & Gilboa, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2903 · Cited by 150
Ladoire, S., Arnould, L., Mignot, G., Coudert, B. P., Rébé, C., Chalmin, F., Vincent, J., Bruchard, M., Chauffert, B., Martin, F., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0831-1 · Cited by 148
Laparoscopic versus open gastrectomy for gastric cancer
Best, L. M., Mughal, M. M., & Gurusamy, K. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011389.pub2 · Cited by 143
Bohling, S. D., & Allison, K. H. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.160 · Cited by 139
Mizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H., & Fujii, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604149 · Cited by 130
Zhang, H., & Sun, H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.001 · Cited by 130
Chen, G., Chen, C., Wang, L., Chang, X., Zheng, P., & Liu, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5163 · Cited by 121
Self-citationLiu, R., Wang, L., Chen, G., Katoh, H., Chen, C., Liu, Y., & Zheng, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3717 · Cited by 121
Self-citationX-Linked Syndrome of Polyendocrinopathy, Immune Dysfunction, and Diarrhea Maps to Xp11.23-Xq13.3
Bennett, C. L., Yoshioka, R., Kiyosawa, H., Barker, D. F., Fain, P. R., Shigeoka, A. O., & Chance, P. F. (2000) · The American Journal of Human Genetics · doi:10.1086/302761 · Cited by 112
FOXP3 expression in tumor cells and implications for cancer progression
Triulzi, T., Tagliabue, E., Balsari, A., & Casalini, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24125 · Cited by 97
Li, W., Wang, L., Katoh, H., Liu, R., Zheng, P., & Liu, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3268 · Cited by 92
Self-citationKatoh, H., Qin, Z. S., Liu, R., Wang, L., Li, W., Li, X., Wu, L., Du, Z., Lyons, R., Liu, C., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.012 · Cited by 75
Self-citationHigh expression of FOXP3 in primary melanoma is associated with tumour progression
Gerber, A., Münst, A., Schlapbach, C., Shafighi, M., Kiermeir, D., H�usler, R., & Hunger, R. E. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12641 · Cited by 72
Taming the Hippo: Raf-1 Controls Apoptosis by Suppressing MST2/Hippo
O’Neill, E. E., & Kölch, W. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1531 · Cited by 68
Zhou, Q., Zheng, X. W., Chen, L., Xu, B., Yang, X. P., Jiang, J., & Wu, C. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445638 · Cited by 66
Foxp3 Expression in p53-dependent DNA Damage Responses
Jung, D. J., Jin, D.-H., Hong, S.-W., Kim, J.-E., Shin, J.-S., Kim, D., Cho, B. J., Hwang, Y. I., Kang, J.-S., & Lee, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047985 · Cited by 63
FOXP3 expression and clinical characteristics of hepatocellular carcinoma
Wang, W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i43.5502 · Cited by 51
Up-regulation of Foxp3 participates in progression of cervical cancer
Zeng, C., Yao, Y., Jie, W., Zhang, M., Hu, X., Zhao, Y. D., Wang, S., Yin, J., & Song, Y. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1348-8 · Cited by 49
Douglass, S. M., Meeson, A. P., Overbeck‐Zubrzycka, D., Brain, J. G., Bennett, M. R., Lamb, C. A., Lennard, T. W. J., Browell, D., Ali, S., & Kirby, J. A. (2014) · The Journal of Pathology · doi:10.1002/path.4381 · Cited by 48
FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells
Hao, Q., Zhang, C., Gao, Y., Wang, S., Li, J., Li, M., Xue, X., Li, W., Zhang, W., & Zhang, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.030 · Cited by 43
Self-citationTristetraprolin inhibits gastric cancer progression through suppression of IL-33
Deng, K., Wang, H., Shan, T., Chen, Y., Zhou, H. Y., Zhao, Q., & Xia, J. (2016) · Scientific Reports · doi:10.1038/srep24505 · Cited by 38
Suh, J. H., Won, K. Y., Kim, G. Y., Bae, G. E., Lim, S., Sung, J., Park, Y.-K., Kim, Y. W., & Lee, J. (2015) · PubMed Central · Cited by 37
Correlation between FOXP3 expression and gastric cancer
Guo, G., He, Z., & Shi, Z. (2016) · Oncology Letters · doi:10.3892/ol.2016.4752 · Cited by 14
Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer
Jiang, C., Wang, W., Yan, W., Zhang, Y., Yang, J., Zhang, S., Zhang, C., Zhang, W., HAN, W., Wang, J., et al. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.264 · Cited by 4
Self-citation
Cited by
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Metadata
- Authors
- Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 42
- Issue
- 5
- Pages
- 1739-1754
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2737785069
- Cited by
- 4,088
- References
- 59
- FWCI
- 267.49
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.